OncoImmunity (private company)

See something wrong or missing? Let us know
Offices:Oslo
Business model:B2B

OncoImmunity is a bioinformatics company offering proprietary machine-learning based software to address the key knowledge gaps in the prediction of bone fide immunogenic neoantigens for personalized cancer immunotherapy.

values in USD


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to OncoImmunity

Name Criteria
Germany Atai Life Sciences
55%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 2
Switzerland Bionomous
55%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
Sweden Monocl
55%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 2
Spain Naru Intelligence
55%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 2
United Kingdom Novai
55%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
United Kingdom Sano Genetics
55%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
Austria Sarcura
55%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 2
Switzerland Scailyte
55%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 2
Switzerland Sophia Genetics
55%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 2
United Kingdom Exiscientia
55%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 2
Top